Montek (Sodium Molybdate (99mo))

Sodium Molybdate, the active ingredient in Montek, is a molybdenum compound presented as an injectable solution for intravenous and ocular use. It is employed in clinical settings where molybdenum supplementation or diagnostic imaging is required, particularly in cases of molybdenum deficiency or specialized ophthalmic procedures. GNH USA supplies Montek as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Montek (sodium molybdate) is used in clinical contexts related to molybdenum metabolism and certain diagnostic procedures.

Molybdenum deficiency: supports restoration of normal enzyme activity in patients with documented deficiency. Ocular angiography: used as a contrast agent to enhance visualization of retinal and choroidal vessels. Intravenous supplementation: provides systemic molybdenum for patients requiring metabolic support.

Sodium molybdate may be associated with a range of adverse reactions.

Common Side Effects: - Nausea or gastrointestinal discomfort. - Headache or dizziness. - Transient visual disturbances following ocular administration. - Injection site pain or erythema. - Mild fatigue or weakness.

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reactions. - Acute renal impairment or elevated serum creatinine. - Hepatic dysfunction with raised transaminases. - Severe hypotension or cardiovascular instability. - Electrolyte disturbances, particularly hyperuricemia.

When using Montek, clinicians should observe the following precautions. - Assess renal function: adjust use in patients with renal impairment. - Monitor liver enzymes: watch for hepatic adverse effects. - Check for hypersensitivity: discontinue if allergic reaction occurs. - Avoid in known molybdenum allergy: contraindicated. - Pregnancy: limited data; use only if potential benefit outweighs risk. - Store at ambient temperature: keep in original container, protect from moisture and light.

Sodium molybdate may interact with other medicines; awareness of interaction severity is important.

Major Interactions (Avoid): - High‑dose copper supplements: may reduce molybdenum absorption. - Certain tetracycline antibiotics: risk of chelation and reduced efficacy.

Moderate Interactions (Monitor Closely): - Vitamin B12 therapy: monitor B12 levels as molybdenum can affect metabolism. - Anticoagulants: observe for altered bleeding risk. - Loop diuretics: watch electrolyte balance, especially uric acid levels.